SCHEMBL25272328

SCHEMBL25272328

Oc1cccc(N2CC3(COC3)C2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF18A Q8NI77 2/20 0.38
▸ DYRK1A Q13627 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ NAPEPLD Q6IQ20 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ LRRK2 Q5S007 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ HPGD P15428 2/20 0.33
▸ GRIA1 P42261 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ MGLL Q99685 1/20 0.32
▸ USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14896890 0.80 HTR3E (0.51) KIF18AGAAALDH1A1
SCHEMBL31696820 0.80 GRIN2D (0.45) KIF18ADYRK1AHDAC4LRRK2ALDH1A1
SCHEMBL1810998 0.80 GRIN2D (0.45) KIF18ADYRK1AHDAC4LRRK2ALDH1A1
SCHEMBL22304475 0.80 KIF18A (0.40) KIF18ADYRK1ANAPEPLDHDAC4LRRK2
SCHEMBL15999329 0.76 KIF18A (0.36) KIF18ADYRK1ANAPEPLDALDH1A1HSD17B10
SCHEMBL12075887 0.75 KIF18A (0.51) KIF18ANAPEPLDHDAC4PIN1RAF1
SCHEMBL30080407 0.74 CRBN (0.52) KIF18AGAANAPEPLDALDH1A1HSD17B10
SCHEMBL4945956 0.74 GAA (0.59) GAAALDH1A1HSD17B10HPGDTSHR
SCHEMBL30440529 0.74 GAA (0.59) GAAALDH1A1HSD17B10HPGDTSHR
SCHEMBL1809768 0.73 KIF18A (0.41) KIF18ANAPEPLDHDAC4ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066377-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-02-27 — — US disclosed
WO-2023114539-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-06-22 — — WO disclosed
WO-2023114539-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066377-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT POLRMT, TFAM, POLM KIF18A 1753/4885DYRK1A 3443/4885GAA 1770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback